No 8 Ventures

Archive: Investment

The Series A Crunch in New Zealand

Posted by: | Investment | Jenny Morel | New Zealand | Venture Capital | 27.03.2017

I believe New Zealand has more angel investors and more incubators per head of population than any other country on the planet. I can’t substantiate that but there is an amazing rich ecosystem of 1,000’s of start-up companies, eager small investors, and a handful of very experienced investor-director-mentors. And from this rich ecosystem stars have […]

No Comments Leave a Comment

Check out the ikeGPS kickstarter project: Introducing Spike smartphone accessory

Posted by: | Glenn Milnes | Innovation | Investment | No8 Investments | Technology | 08.10.2013

We’d like to share a message from Glenn Milnes the CEO of ikeGPS, a No 8 Ventures portfolio company. Introducing Spike: the world’s first laser accurate smartphone accessory As a friend of ike I wanted you to be first to hear about the launch of Spike – the world’s first laser-accurate smartphone accessory that enables […]

Comments Off on Check out the ikeGPS kickstarter project: Introducing Spike smartphone accessory Comments Off on Check out the ikeGPS kickstarter project: Introducing Spike smartphone accessory

OpenCloud secures £5 million investment and OEM agreement with Nokia Siemens Networks

Posted by: | Getting Funded | Glenn Milnes | Innovation | Investment | New Zealand | News | No8 Investments | Technology | Venture Capital | 05.10.2010

We were pleased to participate in a recent investment round into OpenCloud together with Nokia Siemens Networks (NSN) and Advent Ventures, are particularly pleased to see OpenCloud continue on its a rapid growth path. OpenCloud’s technology platform is being deployed into the heart of the world’s largest telecommunications companies – with 13 new tier-1 customer […]

Comments Off on OpenCloud secures £5 million investment and OEM agreement with Nokia Siemens Networks Comments Off on OpenCloud secures £5 million investment and OEM agreement with Nokia Siemens Networks

Proacta in Phase 2 clinical trials

Posted by: | Glenn Milnes | Innovation | Investment | No8 Investments | Venture Capital | 13.07.2009

Proacta’s lead compound, PR104, has entered Phase 2 clinical trials. This is an exciting milestone for the company. After showing signs of activity in early Phase 1 clinical trials – which establish how much of the drug can safely be administered, PR104 is now being evaluated in Phase 2 trials to test its efficacy for […]

Comments Off on Proacta in Phase 2 clinical trials Comments Off on Proacta in Phase 2 clinical trials

Sydney Venture Capital Conference

Posted by: | Investment | Jenny Morel | Venture Capital | 18.03.2009

At the Asian VC Journal Sydney conference a week ago, there was a lot of talk from the hard-pressed private equity guys – who have lost their bank leverage – about the great buying opportunities in the market now.  However, the real opportunity has to be in the venture capital end of the market, which never […]

Comments Off on Sydney Venture Capital Conference Comments Off on Sydney Venture Capital Conference